Archford Capital Strategies’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-280
| Closed | -$14K | – | 342 |
|
|
2019
Q2 | $14K | Hold |
280
| – | – | 0.01% | 380 |
|
|
2019
Q1 | $15K | Hold |
280
| – | – | 0.01% | 362 |
|
|
2018
Q4 | $13K | Hold |
280
| – | – | 0.01% | 356 |
|
|
2018
Q3 | $14K | Hold |
280
| – | – | 0.01% | 389 |
|
|
2018
Q2 | $14K | Buy |
280
+8
| +3% | +$400 | ﹤0.01% | 396 |
|
|
2018
Q1 | $12K | Buy |
+272
| New | +$12K | 0.01% | 320 |
|
|
2017
Q2 | – | Sell |
-698
| Closed | -$37K | – | 360 |
|
|
2017
Q1 | $37K | Buy |
698
+192
| +38% | +$10.2K | 0.01% | 308 |
|
|
2016
Q4 | $24K | Sell |
506
-180
| -26% | -$8.54K | 0.01% | 307 |
|
|
2016
Q3 | $36K | Hold |
686
| – | – | 0.01% | 286 |
|
|
2016
Q2 | $37K | Buy |
+686
| New | +$37K | 0.02% | 278 |
|
|
2016
Q1 | – | Sell |
-620
| Closed | -$32K | – | 342 |
|
|
2015
Q4 | $32K | Buy |
620
+40
| +7% | +$2.07K | 0.01% | 314 |
|
|
2015
Q3 | $28K | Sell |
580
-1,566
| -73% | -$75.6K | 0.02% | 238 |
|
|
2015
Q2 | $112K | Sell |
2,146
-45
| -2% | -$2.35K | 0.08% | 148 |
|
|
2015
Q1 | $126K | Hold |
2,191
| – | – | 0.09% | 140 |
|
|
2014
Q4 | $117K | Sell |
2,191
-4,794
| -69% | -$256K | 0.09% | 146 |
|
|
2014
Q3 | $401K | Buy |
6,985
+367
| +6% | +$21.1K | 0.32% | 88 |
|
|
2014
Q2 | $442K | Sell |
6,618
-268
| -4% | -$17.9K | 0.34% | 84 |
|
|
2014
Q1 | $460K | Buy |
+6,886
| New | +$460K | 0.38% | 81 |
|